Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
- PMID: 29569621
- DOI: 10.1038/nrendo.2018.24
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
Abstract
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a combination of signs and symptoms of androgen excess and ovarian dysfunction in the absence of other specific diagnoses. The aetiology of this syndrome remains largely unknown, but mounting evidence suggests that PCOS might be a complex multigenic disorder with strong epigenetic and environmental influences, including diet and lifestyle factors. PCOS is frequently associated with abdominal adiposity, insulin resistance, obesity, metabolic disorders and cardiovascular risk factors. The diagnosis and treatment of PCOS are not complicated, requiring only the judicious application of a few well-standardized diagnostic methods and appropriate therapeutic approaches addressing hyperandrogenism, the consequences of ovarian dysfunction and the associated metabolic disorders. This article aims to provide a balanced review of the latest advances and current limitations in our knowledge about PCOS while also providing a few clear and simple principles, based on current evidence-based clinical guidelines, for the proper diagnosis and long-term clinical management of women with PCOS.
Similar articles
-
The latest reports and treatment methods on polycystic ovary syndrome.Ann Med. 2024 Dec;56(1):2357737. doi: 10.1080/07853890.2024.2357737. Epub 2024 Jul 4. Ann Med. 2024. PMID: 38965663 Free PMC article. Review.
-
Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.Nutr Res Rev. 2017 Jun;30(1):97-105. doi: 10.1017/S0954422416000287. Epub 2017 Feb 22. Nutr Res Rev. 2017. PMID: 28222828 Review.
-
Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.Mol Metab. 2020 May;35:100937. doi: 10.1016/j.molmet.2020.01.001. Epub 2020 Feb 5. Mol Metab. 2020. PMID: 32244180 Free PMC article.
-
Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.Clin Chim Acta. 2020 Mar;502:214-221. doi: 10.1016/j.cca.2019.11.003. Epub 2019 Nov 13. Clin Chim Acta. 2020. PMID: 31733195 Review.
-
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.Fertil Steril. 2004 Jan;81(1):19-25. doi: 10.1016/j.fertnstert.2003.10.004. Fertil Steril. 2004. PMID: 14711538
Cited by
-
The impact of herbal medicine in regulating intestinal flora on female reproductive disorders.Front Pharmacol. 2022 Oct 14;13:1026141. doi: 10.3389/fphar.2022.1026141. eCollection 2022. Front Pharmacol. 2022. PMID: 36313343 Free PMC article. Review.
-
Thin endometrium is associated with the risk of hypertensive disorders of pregnancy in fresh IVF/ICSI embryo transfer cycles: a retrospective cohort study of 9,266 singleton births.Reprod Biol Endocrinol. 2021 Apr 9;19(1):55. doi: 10.1186/s12958-021-00738-9. Reprod Biol Endocrinol. 2021. PMID: 33836788 Free PMC article.
-
Female sexual function in different phenotypes of polycystic ovarian syndrome: a comparative cross-sectional study.Sci Rep. 2022 Nov 11;12(1):19317. doi: 10.1038/s41598-022-24026-7. Sci Rep. 2022. PMID: 36369524 Free PMC article.
-
Regulatory mechanisms of HMGB1 and its receptors in polycystic ovary syndrome-driven gravid uterine inflammation.FEBS J. 2023 Apr;290(7):1874-1906. doi: 10.1111/febs.16678. Epub 2022 Dec 8. FEBS J. 2023. PMID: 36380688 Free PMC article.
-
In Search of New Therapeutics-Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond.Int J Mol Sci. 2020 Sep 25;21(19):7054. doi: 10.3390/ijms21197054. Int J Mol Sci. 2020. PMID: 32992734 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
